Publication: Assessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives
Files
Program
KU-Authors
KU Authors
Co-Authors
Kretschmer, A.
Van Den Bergh, R.C.N., Martini, A.
Marra, G.
Valerio, M.
Tsaur, I.
Heidegger, I.
Kasivisvanathan, V.
Kesch, C.
Preisser, F.
Fankhauser, C.D.
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
NO
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
With the therapeutic landscape of advanced prostate cancer rapidly evolving and oncological benefits being shown for a plethora of new agents and indications, health-related quality of life (HRQOL)-associated evidence is still subpar. In the current comprehensive review, we discuss the importance of HRQOL for patients with advanced PC (metastatic hormone-sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castrationresistant prostate cancer (nmCRPC)), and present the most frequently used tools to evaluate HRQOL in recent randomized trials. Furthermore, we discuss the ease of use of these validated questionnaires for clinicians and try to focus on the suggested appropriate use in clinical practice, as well as potential strategies for improvement of HRQOL evaluation in these clinical scenarios of advanced prostate cancer.
Source
Publisher
Multidisciplinary Digital Publishing Institute (MDPI)
Subject
Oncology
Citation
Has Part
Source
Cancers
Book Series Title
Edition
DOI
10.3390/cancers14010147